The HIV epidemic has led to large increases in the frequency of smear-negative pulmonary tuberculosis, which has poor treatment outcomes and excessive early mortality compared with smear-positive disease. We used a combination of systematic review, document analysis, and global expert opinion to review the extent of this problem. We also looked at policies of national tuberculosis control programmes for the diagnosis of smear-negative pulmonary tuberculosis to assess their coverage, identify the diagnostic difficulties, and find ways to improve the diagnosis of this type of tuberculosis, with a focus on resource-constrained settings with high HIV infection rates. We propose that the internationally recommended algorithm for the diagnosis of smear-negative pulmonary tuberculosis should be revised to include HIV status, severity of AIDS and tuberculosis, and early use of chest radiography in the decision tree. Increased use of promising methods of diagnosis such as sputum liquefaction and concentration and increased availability of fluorescence microscopy should be explored and encouraged. Culturing of sputum in resource-constrained settings with high HIV infection rates should also be encouraged, existing facilities should be made full use of and upgraded, and effective quality-assurance systems should be used. Innovative ways to address human resources issues involved in addressing the diagnostic difficulties are also needed. The development of rapid, simple, and accurate tuberculosis diagnostic tools with applicability at point of care and remote location is essential. To achieve these goals, greater political commitment, scientific interest, and investment are needed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(07)60284-0DOI Listing

Publication Analysis

Top Keywords

smear-negative pulmonary
16
pulmonary tuberculosis
16
diagnosis smear-negative
12
hiv infection
12
resource-constrained settings
12
tuberculosis
8
diagnostic difficulties
8
settings high
8
high hiv
8
infection rates
8

Similar Publications

This study aimed to evaluate the diagnostic value of rapid simultaneous RNA amplification and testing for tuberculosis (SAT-TB) in smear-negative pulmonary tuberculosis (PTB). We performed a multicenter prospective analysis of 206 patients with smear-negative suspected PTB between December 2018 and March 2022. We collected sputum or bronchoalveolar lavage fluid (BALF) for simultaneous SAT-TB and Xpert Mycobacterium tuberculosis/rifampin (MTB/RIF) assays.

View Article and Find Full Text PDF

Study on the early diagnostic value of nanopore sequencing in alveolar lavage fluid smear-negative pulmonary tuberculosis.

Braz J Microbiol

December 2024

Department of Infectious Diseases, Xiangya Medical College, Zhuzhou Central Hospital (Zhuzhou Hospital, Central South University), Zhuzhou, Hunan, 412007, China.

The objective of this study was to investigate the early diagnostic value of nanopore sequencing in alveolar lavage smear-negative pulmonary tuberculosis (PTB). A prospective study was conducted on patients hospitalized at Zhuzhou Central Hospital from October 2021 to June 2022 and suspected to have PTB. Alveolar lavage fluid specimens were collected from these patients and simultaneously subjected to centrifugal bacterial collection smear method in a sandwich cup, bifidobacteria solid culture (referred to as culture), Mycobacterium tuberculosis-DNA (TB-DNA), and nanopore sequencing for detection of Mycobacterium tuberculosis.

View Article and Find Full Text PDF

Ethiopia is among the countries most heavily affected by tuberculosis, where it is the leading cause of morbidity, the third cause of hospital admission and the second cause of death. To improve tuberculosis management and control, the early detection of cases, effective treatment and the persistent evaluation of treatment outcomes are vital issues that should be taken into consideration. This study was designed to determine the treatment outcomes and associated risk factors among TB patients registered at Adare General Hospital in Southern Ethiopia.

View Article and Find Full Text PDF

Microbiological aspects and clinical impact of lower lung field tuberculosis: An observational cohort study in Peru.

Int J Infect Dis

January 2025

Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA; Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address:

Article Synopsis
  • Approximately 40% of global tuberculosis cases go undiagnosed, with lower lung field TB (LLF TB) frequently misidentified as other lung issues, causing treatment delays.
  • An observational study in Lima, Peru, found that among 1316 pulmonary TB patients, 6% had LLF TB, which tended to be smear-negative, indicating a less typical presentation of the disease.
  • LLF TB patients showed less improvement in their respiratory health after 2 months of treatment, yet they had better final treatment outcomes compared to those with non-LLF TB, highlighting the need for optimized care for this specific group.
View Article and Find Full Text PDF
Article Synopsis
  • Tuberculosis (TB) is still widespread in Malaysia, and using cost-effective methods like chest radiography can help in early detection to mitigate its impact, though many cases exhibit normal X-ray results.
  • A study of 56 confirmed smear-positive pulmonary TB cases revealed that about 43% had normal chest radiographs, despite presenting symptoms and positive sputum tests.
  • Factors linked to these normal findings included being under 18, being a student, being single, and being asymptomatic, highlighting the need for thorough testing beyond radiographs to avoid misdiagnosis during outbreaks.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!